These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1415 related articles for article (PubMed ID: 22449319)

  • 1. Bariatric surgery versus intensive medical therapy in obese patients with diabetes.
    Schauer PR; Kashyap SR; Wolski K; Brethauer SA; Kirwan JP; Pothier CE; Thomas S; Abood B; Nissen SE; Bhatt DL
    N Engl J Med; 2012 Apr; 366(17):1567-76. PubMed ID: 22449319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.
    Schauer PR; Bhatt DL; Kirwan JP; Wolski K; Brethauer SA; Navaneethan SD; Aminian A; Pothier CE; Kim ES; Nissen SE; Kashyap SR;
    N Engl J Med; 2014 May; 370(21):2002-13. PubMed ID: 24679060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.
    Schauer PR; Bhatt DL; Kirwan JP; Wolski K; Aminian A; Brethauer SA; Navaneethan SD; Singh RP; Pothier CE; Nissen SE; Kashyap SR;
    N Engl J Med; 2017 Feb; 376(7):641-651. PubMed ID: 28199805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bariatric surgery versus conventional medical therapy for type 2 diabetes.
    Mingrone G; Panunzi S; De Gaetano A; Guidone C; Iaconelli A; Leccesi L; Nanni G; Pomp A; Castagneto M; Ghirlanda G; Rubino F
    N Engl J Med; 2012 Apr; 366(17):1577-85. PubMed ID: 22449317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment.
    Kashyap SR; Bhatt DL; Wolski K; Watanabe RM; Abdul-Ghani M; Abood B; Pothier CE; Brethauer S; Nissen S; Gupta M; Kirwan JP; Schauer PR
    Diabetes Care; 2013 Aug; 36(8):2175-82. PubMed ID: 23439632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial.
    Hofsø D; Fatima F; Borgeraas H; Birkeland KI; Gulseth HL; Hertel JK; Johnson LK; Lindberg M; Nordstrand N; Cvancarova Småstuen M; Stefanovski D; Svanevik M; Gretland Valderhaug T; Sandbu R; Hjelmesæth J
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):912-924. PubMed ID: 31678062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy for Type 2 Diabetes Mellitus in Nonseverely Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Sha Y; Huang X; Ke P; Wang B; Yuan H; Yuan W; Wang Y; Zhu X; Yan Y
    Obes Surg; 2020 May; 30(5):1660-1670. PubMed ID: 31912466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery for weight loss in adults.
    Colquitt JL; Pickett K; Loveman E; Frampton GK
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003641. PubMed ID: 25105982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of bariatric surgery on insulin-treated type 2 diabetes patients.
    Lemus R; Karni D; Hong D; Gmora S; Breau R; Anvari M
    Surg Endosc; 2018 Feb; 32(2):990-1001. PubMed ID: 28842774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obese Patients with Type 2 Diabetes: Outcomes After Laparoscopic Sleeve Gastrectomy.
    Viscido G; Gorodner V; Signorini FJ; Biasoni AC; Navarro L; Rubin G; Obeide L; Moser F
    J Laparoendosc Adv Surg Tech A; 2019 May; 29(5):655-662. PubMed ID: 30452318
    [No Abstract]   [Full Text] [Related]  

  • 11. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect.
    Lee WJ; Chong K; Lin YH; Wei JH; Chen SC
    Obes Surg; 2014 Sep; 24(9):1552-62. PubMed ID: 24965545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the impact of sleeve gastrectomy and gastric bypass on metabolic control of diabetes? A clinic-based cohort of Mediterranean diabetic patients.
    Bruno G; Gruden G; Barutta F; Cavallo Perin P; Morino M; Toppino M
    Surg Obes Relat Dis; 2015; 11(5):1014-9. PubMed ID: 25979204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.
    Salminen P; Helmiö M; Ovaska J; Juuti A; Leivonen M; Peromaa-Haavisto P; Hurme S; Soinio M; Nuutila P; Victorzon M
    JAMA; 2018 Jan; 319(3):241-254. PubMed ID: 29340676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of early type 2 diabetes improvement after gastric bypass and sleeve gastrectomy: medication cessation at discharge predicts 1-year outcomes.
    Heshmati K; Harris DA; Aliakbarian H; Tavakkoli A; Sheu EG
    Surg Obes Relat Dis; 2019 Dec; 15(12):2025-2032. PubMed ID: 31711946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.
    Peterli R; Wölnerhanssen BK; Peters T; Vetter D; Kröll D; Borbély Y; Schultes B; Beglinger C; Drewe J; Schiesser M; Nett P; Bueter M
    JAMA; 2018 Jan; 319(3):255-265. PubMed ID: 29340679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year.
    Nocca D; Guillaume F; Noel P; Picot MC; Aggarwal R; El Kamel M; Schaub R; de Seguin de Hons C; Renard E; Fabre JM
    Obes Surg; 2011 Jun; 21(6):738-43. PubMed ID: 21468625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INCREASED BONE TURNOVER IN TYPE 2 DIABETES PATIENTS RANDOMIZED TO BARIATRIC SURGERY VERSUS MEDICAL THERAPY AT 5 YEARS.
    Crawford MR; Pham N; Khan L; Bena JF; Schauer PR; Kashyap SR
    Endocr Pract; 2018 Mar; 24(3):256-264. PubMed ID: 29144812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study.
    Ikramuddin S; Korner J; Lee WJ; Thomas AJ; Connett JE; Bantle JP; Leslie DB; Wang Q; Inabnet WB; Jeffery RW; Chong K; Chuang LM; Jensen MD; Vella A; Ahmed L; Belani K; Billington CJ
    JAMA; 2018 Jan; 319(3):266-278. PubMed ID: 29340678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.
    Ikramuddin S; Korner J; Lee WJ; Connett JE; Inabnet WB; Billington CJ; Thomas AJ; Leslie DB; Chong K; Jeffery RW; Ahmed L; Vella A; Chuang LM; Bessler M; Sarr MG; Swain JM; Laqua P; Jensen MD; Bantle JP
    JAMA; 2013 Jun; 309(21):2240-9. PubMed ID: 23736733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of laparoscopic gastric bypass
    Yan Y; Wang F; Chen H; Zhao X; Yin D; Hui Y; Ma N; Yang C; Zheng Z; Zhang T; Xu N; Wang G
    Br J Biomed Sci; 2021 Jan; 78(1):35-40. PubMed ID: 32698681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.